Portable Point-of-Care Device for Dual Detection of Glucose-6-Phosphate Dehydrogenase Deficiency and Hemoglobin in Low-Resource Settings
Biosensors · 2025
DOI: 10.3390/bios15090577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2025. Verfasst von Rehab Osman Taha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand. Hauptthemen laut MEDLINE: Glucosephosphate Dehydrogenase Deficiency, Point-of-Care Systems, Hemoglobins, Biosensing Techniques. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chulabhorn International College of Medicine, Thammasat University, NRCT, the National Research Council of Thailand (NRCT).
Abstract (Originalsprache)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzymopathy with significant clinical implications, particularly in malaria-endemic regions and in the management of neonatal hyperbilirubinemia. Timely and accurate detection of G6PD deficiency is critical to prevent life-threatening hemolytic events following oxidative drug administration. This study evaluated the MyG6PD device, a quantitative point-of-care (PoC) tool, for the assessment of hemoglobin concentration and G6PD enzyme activity. Analytical performance was benchmarked against laboratory spectrophotometry and the STANDARD G6PD Analyzer™ (SD Biosensor; Suwon-si, Republic of Korea). MyG6PD demonstrated excellent linearity (R2 ≥ 0.99), accuracy (bias < ±15%), and precision (CV < 15%) across normal, intermediate, and deficient activity ranges, including heterozygous females with intermediate phenotypes. The device’s compact, battery-operated design, rapid turnaround, and minimal training requirements support its use in decentralized and resource-limited settings. Furthermore, cost-effective consumables and robust detection of intermediate activity highlight its potential for large-scale deployment. Overall, MyG6PD provides a reliable, accessible, and clinically actionable solution for urgent G6PD deficiency screening, enabling safer administration of oxidative therapies and improving patient outcomes in high-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
- Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathum Thani 12120, Thailand.
- Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
ORCID-Profile: Runtikan Pochairach
Förderung
- Chulabhorn International College of Medicine, Thammasat University
- NRCT
- the National Research Council of Thailand (NRCT)
Zitieren
APA
Taha, R. O., Youngvises, N., Pochairach, R., Phompradit, P., & Na-Bangchang, K. (2025). Portable Point-of-Care Device for Dual Detection of Glucose-6-Phosphate Dehydrogenase Deficiency and Hemoglobin in Low-Resource Settings. Biosensors. https://doi.org/10.3390/bios15090577
Vancouver
Taha RO, Youngvises N, Pochairach R, Phompradit P, Na-Bangchang K. Portable Point-of-Care Device for Dual Detection of Glucose-6-Phosphate Dehydrogenase Deficiency and Hemoglobin in Low-Resource Settings. Biosensors. 2025. doi:10.3390/bios15090577
BibTeX
@article{Taha2025,
author = {Taha, Rehab Osman and Youngvises, Napaporn and Pochairach, Runtikan and Phompradit, Papichaya and Na-Bangchang, Kesara},
title = {Portable Point-of-Care Device for Dual Detection of Glucose-6-Phosphate Dehydrogenase Deficiency and Hemoglobin in Low-Resource Settings},
journal = {Biosensors},
year = {2025},
doi = {10.3390/bios15090577}
}
EUVIMED